Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first3,001 to 3,020 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| SLC22A8 solute carrier family 22 member 8 | 9376 HGNC:10972 | 1 | 35 | 2 | 16 | 883 | 2,037 |
| GRPR gastrin releasing peptide receptor | 2925 HGNC:4609 | 1 | 31 | 0 | 0 | 898 | 2,036 |
| DYSF dysferlin | 8291 HGNC:3097 | 1 | 49 | 0 | 0 | 899 | 2,035 |
| ERCC8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 1161 HGNC:3439 | 1 | 41 | 0 | 0 | 1,116 | 2,033 |
| PGC progastricsin | 5225 HGNC:8890 | 1 | 37 | 0 | 0 | 868 | 2,033 |
| ACOD1 aconitate decarboxylase 1 | 730249 HGNC:33904 | 1 | 14 | 0 | 0 | 1,294 | 2,030 |
| MIR181C microRNA 181c | 406957 HGNC:31552 | 0 | 0 | 0 | 0 | 788 | 2,030 |
| TOX thymocyte selection associated high mobility group box | 9760 HGNC:18988 | 1 | 61 | 0 | 0 | 1,689 | 2,030 |
| CHP1 calcineurin like EF-hand protein 1 | 11261 HGNC:17433 | 1 | 19 | 0 | 0 | 1,053 | 2,029 |
| NR1D1 nuclear receptor subfamily 1 group D member 1 | 9572 HGNC:7962 | 1 | 54 | 0 | 0 | 1,343 | 2,029 |
| SORD sorbitol dehydrogenase | 6652 HGNC:11184 | 1 | 22 | 0 | 0 | 618 | 2,028 |
| ACSL1 acyl-CoA synthetase long chain family member 1 | 2180 HGNC:3569 | 1 | 86 | 0 | 0 | 1,371 | 2,026 |
| MASP2 MBL associated serine protease 2 | 10747 HGNC:6902 | 1 | 206 | 1 | 7 | 665 | 2,026 |
| HDAC11 histone deacetylase 11 | 79885 HGNC:19086 | 1 | 18 | 13 | 410 | 1,188 | 2,024 |
| PRG4 proteoglycan 4 | 10216 HGNC:9364 | 1 | 32 | 0 | 0 | 1,053 | 2,024 |
| CD1B CD1b molecule | 910 HGNC:1635 | 1 | 34 | 0 | 0 | 1,440 | 2,023 |
| CILK1 ciliogenesis associated kinase 1 | 22858 HGNC:21219 | 1 | 42 | 0 | 0 | 1,094 | 2,020 |
| INA internexin neuronal intermediate filament protein alpha | 9118 HGNC:6057 | 1 | 31 | 0 | 0 | 1,432 | 2,019 |
| PDHA1 pyruvate dehydrogenase E1 subunit alpha 1 | 5160 HGNC:8806 | 1 | 40 | 0 | 0 | 1,122 | 2,019 |
| APLNR apelin receptor | 187 HGNC:339 | 1 | 119 | 1 | 8 | 941 | 2,018 |
Code
curl "https://conductscience.org/api/genes/v1?page=151"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=151
{
"data": {
"total": 193990,
"results": [
{
"id": "9376",
"title": "SLC22A8: solute carrier family 22 member 8",
"summary": "NCBI Gene 9376. 1 protein, 35 patents, 2 drugs, 16 trials, 883 NIH grants and 2,037 papers.",
"record": "/library/genes/9376",
"gene_id": 9376,
"symbol": "SLC22A8",
"name": "solute carrier family 22 member 8",
"hgnc_id": "HGNC:10972",
"counts": {
"proteins": 1,
"patents": 35,
"drugs": 2,
"trials": 16,
"grants": 883,
"papers": 2037
}
},
{
"id": "2925",
"title": "GRPR: gastrin releasing peptide receptor",
"summary": "NCBI Gene 2925. 1 protein, 31 patents, 0 drugs, 0 trials, 898 NIH grants and 2,036 papers.",
"record": "/library/genes/2925",
"gene_id": 2925,
"symbol": "GRPR",
"name": "gastrin releasing peptide receptor",
"hgnc_id": "HGNC:4609",
"counts": {
"proteins": 1,
"patents": 31,
"drugs": 0,
"trials": 0,
"grants": 898,
"papers": 2036
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=152",
"request_id": "EQguvx0LHQPve89-"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant